-
Something wrong with this record ?
Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study
P. Boffano, AM. Agnone, F. Neirotti, R. Bonfiglio, M. Brucoli, M. Ruslin, A. Durković, M. Milosavljević, V. Konstantinovic, JCV. Rodríguez, TR. Santamarta, C. Meyer, A. Louvrier, A. Michel-Guillaneux, E. Bertin, T. Starch-Jensen, AJ. Tadic, BV....
Language English Country France
Document type Journal Article, Multicenter Study
- MeSH
- Bisphosphonate-Associated Osteonecrosis of the Jaw * epidemiology etiology therapy diagnosis MeSH
- Adult MeSH
- Bone Density Conservation Agents therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Risk Factors MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Sex Factors MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Geographicals
- Europe MeSH
INTRODUCTION: The purpose of this European multicenter study was to describe the general characteristics and risk factors of MRONJ lesions as well as their clinical diagnosis and management at different European Oral and Maxillofacial Surgery centers, in order to minimize selections biases and provide information about the epidemiology, etiopathogenesis, and the current trends in the treatment of MRONJ across Europe. MATERIALS AND METHODS: The following data were registered for each patient: gender; age at MRONJ diagnosis; past medical history; indication for antiresorptive or antiangiogenic therapy; type of antiresorptive medication; local risk factor for MRONJ; MRONJ Stage; anatomic location and symptoms; treatment; surgical complications; recurrence. RESULTS: A total of 537 patients (375 females, 162 males) with MRONJ were included. Statistically significant associations were found between patients with metastatic bone disease and recurrences (P < 0.0005) and between advanced MRONJ stages (stages 2 and 3) and recurrences (P < 0.005). Statistically significant associations were also found between male gender and recurrences (P < 0.05), and between MRONJ maxillary sites and recurrences (P < 0.0000005). CONCLUSIONS: A longer mean duration of antiresorptive medications before MRONJ onset was observed in patients affected by osteoporosis, whereas a shorter mean duration was observed in all metastatic bone cancer patients, and in particular in those affected by prostate cancer with bone metastases or multiple myeloma. Surgery plays an important role for the management of MRONJ lesions.
Centro Medico Teknon Barcellona Spain
Department for Maxillofacial Surgery University Hospital Dubrava Zagreb Croatia
Department of Oral and Maxillofacial Surgery Aalborg University Hospital Aalborg Denmark
Department of Oral surgery Faculty of Dental medicine Medical University of Plovdiv Bulgaria
Faculty of Medicine University of Novi Sad Dental Clinic of Vojvodina Novi Sad Serbia
Hasanuddin University Makassar Indonesia
KAT General Hospital Athens Greece
Medical University of Gdansk Gdansk Poland
University Medical Centre Ljubljana Ljubljana Slovenia
University of Belgrade Belgrade Serbia
University of Eastern Piedmont Novara Italy
University of Pécs Medical School Dept Oral and Maxillofacial Surgery 1 Tüzér st 7623 Pécs Hungary
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019164
- 003
- CZ-PrNML
- 005
- 20241024111716.0
- 007
- ta
- 008
- 241015s2024 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jormas.2024.101931 $2 doi
- 035 __
- $a (PubMed)38821192
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Boffano, Paolo $u University of Eastern Piedmont, Novara, Italy. Electronic address: paolo.boffano@gmail.com
- 245 10
- $a Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study / $c P. Boffano, AM. Agnone, F. Neirotti, R. Bonfiglio, M. Brucoli, M. Ruslin, A. Durković, M. Milosavljević, V. Konstantinovic, JCV. Rodríguez, TR. Santamarta, C. Meyer, A. Louvrier, A. Michel-Guillaneux, E. Bertin, T. Starch-Jensen, AJ. Tadic, BV. Bajkin, S. Dugast, H. Bertin, P. Corre, J. Szalma, T. Dovsak, L. Prodnik, R. Mottl, E. Dediol, B. Kos, AV. Ontanon, P. Stathopoulos, K. Tsekoura, A. Polcyn, A. Michcik, L. Zaleckas, N. Pavlov, A. Sapundzhiev, P. Uchikov, P. Pechalova
- 520 9_
- $a INTRODUCTION: The purpose of this European multicenter study was to describe the general characteristics and risk factors of MRONJ lesions as well as their clinical diagnosis and management at different European Oral and Maxillofacial Surgery centers, in order to minimize selections biases and provide information about the epidemiology, etiopathogenesis, and the current trends in the treatment of MRONJ across Europe. MATERIALS AND METHODS: The following data were registered for each patient: gender; age at MRONJ diagnosis; past medical history; indication for antiresorptive or antiangiogenic therapy; type of antiresorptive medication; local risk factor for MRONJ; MRONJ Stage; anatomic location and symptoms; treatment; surgical complications; recurrence. RESULTS: A total of 537 patients (375 females, 162 males) with MRONJ were included. Statistically significant associations were found between patients with metastatic bone disease and recurrences (P < 0.0005) and between advanced MRONJ stages (stages 2 and 3) and recurrences (P < 0.005). Statistically significant associations were also found between male gender and recurrences (P < 0.05), and between MRONJ maxillary sites and recurrences (P < 0.0000005). CONCLUSIONS: A longer mean duration of antiresorptive medications before MRONJ onset was observed in patients affected by osteoporosis, whereas a shorter mean duration was observed in all metastatic bone cancer patients, and in particular in those affected by prostate cancer with bone metastases or multiple myeloma. Surgery plays an important role for the management of MRONJ lesions.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a bisfosfonátová osteonekróza čelistí $x epidemiologie $x etiologie $x terapie $x diagnóza $7 D059266
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a inhibitory kostní resorpce $x terapeutické užití $7 D050071
- 650 _2
- $a sexuální faktory $7 D012737
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Agnone, Anna Maria $u University of Eastern Piedmont, Novara, Italy
- 700 1_
- $a Neirotti, Francesca $u University of Eastern Piedmont, Novara, Italy
- 700 1_
- $a Bonfiglio, Roberta $u University of Eastern Piedmont, Novara, Italy
- 700 1_
- $a Brucoli, Matteo $u University of Eastern Piedmont, Novara, Italy
- 700 1_
- $a Ruslin, Muhammad $u Hasanuddin University, Makassar, Indonesia
- 700 1_
- $a Durković, Ana $u University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Milosavljević, Marija $u University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Konstantinovic, Vitomir $u University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Rodríguez, Juan Carlos de Vicente $u Maxillofacial Department in the Hospital Universitario Central de Asturias from Oviedo, Asturias, Spain
- 700 1_
- $a Santamarta, Tania Rodríguez $u Maxillofacial Department in the Hospital Universitario Central de Asturias from Oviedo, Asturias, Spain
- 700 1_
- $a Meyer, Christophe $u Université de Franche-Comté, CHU Besançon, Chirurgie maxillo-faciale, stomatologie et odontologie hospitalière, F-25000 Besançon, France
- 700 1_
- $a Louvrier, Aurelien $u Université de Franche-Comté, CHU Besançon, Chirurgie maxillo-faciale, stomatologie et odontologie hospitalière, F-25000 Besançon, France
- 700 1_
- $a Michel-Guillaneux, Alexandre $u Université de Franche-Comté, CHU Besançon, Chirurgie maxillo-faciale, stomatologie et odontologie hospitalière, F-25000 Besançon, France
- 700 1_
- $a Bertin, Eugenie $u Université de Franche-Comté, CHU Besançon, Chirurgie maxillo-faciale, stomatologie et odontologie hospitalière, F-25000 Besançon, France
- 700 1_
- $a Starch-Jensen, Thomas $u Department of Oral and Maxillofacial Surgery, Aalborg University Hospital, Aalborg, Denmark
- 700 1_
- $a Tadic, Ana J $u Faculty of Medicine, University of Novi Sad, Dental Clinic of Vojvodina, Novi Sad, Serbia
- 700 1_
- $a Bajkin, Branislav V $u Faculty of Medicine, University of Novi Sad, Dental Clinic of Vojvodina, Novi Sad, Serbia
- 700 1_
- $a Dugast, Sophie $u Nantes Université, CHU Nantes, Service de chirurgie maxillo-faciale et stomatologie, F-4400 Nantes, France
- 700 1_
- $a Bertin, Helios $u Nantes Université, CHU Nantes, Service de chirurgie maxillo-faciale et stomatologie, F-4400 Nantes, France
- 700 1_
- $a Corre, Pierre $u Nantes Université, CHU Nantes, Service de chirurgie maxillo-faciale et stomatologie, F-4400 Nantes, France
- 700 1_
- $a Szalma, József $u University of Pécs, Medical School, Dept. Oral and Maxillofacial Surgery, 1. Tüzér st., 7623 Pécs, Hungary
- 700 1_
- $a Dovsak, Tadej $u University Medical Centre Ljubljana, Ljubljana, Slovenia
- 700 1_
- $a Prodnik, Luka $u University Medical Centre Ljubljana, Ljubljana, Slovenia
- 700 1_
- $a Mottl, Radovan $u Department of Dentistry, Faculty of Medicine in Hradec Kralove, Charles University and University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech Republic
- 700 1_
- $a Dediol, Emil $u Department for Maxillofacial Surgery, University Hospital Dubrava, Zagreb, Croatia
- 700 1_
- $a Kos, Boris $u Department for Maxillofacial Surgery, University Hospital Dubrava, Zagreb, Croatia
- 700 1_
- $a Ontanon, Adaia Valls $u Centro Medico Teknon, Barcellona, Spain
- 700 1_
- $a Stathopoulos, Panagiotis $u KAT General Hospital, Athens, Greece
- 700 1_
- $a Tsekoura, Konstantina $u KAT General Hospital, Athens, Greece
- 700 1_
- $a Polcyn, Adam $u Medical University of Gdansk, Gdansk, Poland
- 700 1_
- $a Michcik, Adam $u Medical University of Gdansk, Gdansk, Poland
- 700 1_
- $a Zaleckas, Linas $u Centre of Oral and Maxillofacial Surgery, Institute of Dentistry, Faculty of Medicine, Vilnius university, Vilnius, Lithuania
- 700 1_
- $a Pavlov, Nikolai $u Department of Oral surgery, Faculty of Dental medicine, Medical University of Plovdiv, Bulgaria
- 700 1_
- $a Sapundzhiev, Angel $u Department of Oral surgery, Faculty of Dental medicine, Medical University of Plovdiv, Bulgaria
- 700 1_
- $a Uchikov, Petar $u Department of Oral surgery, Faculty of Dental medicine, Medical University of Plovdiv, Bulgaria
- 700 1_
- $a Pechalova, Petia $u Department of Oral surgery, Faculty of Dental medicine, Medical University of Plovdiv, Bulgaria
- 773 0_
- $w MED00201265 $t Journal of stomatology, oral and maxillofacial surgery $x 2468-7855 $g Roč. 125, č. 5S1 (2024), s. 101931
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38821192 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111709 $b ABA008
- 999 __
- $a ok $b bmc $g 2201788 $s 1231137
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 125 $c 5S1 $d 101931 $e 20240529 $i 2468-7855 $m Journal of stomatology, oral and maxillofacial surgery $n J Stomatol Oral Maxillofac Surg $x MED00201265
- LZP __
- $a Pubmed-20241015